IgG4 Cholangiopathy
Author Information
Author(s): Yoh Zen, Nakanuma Yasuni
Primary Institution: Institute of Liver Studies, King's College Hospital
Hypothesis
IgG4 cholangiopathy is a distinct entity that should be differentiated from primary sclerosing cholangitis.
Conclusion
IgG4-related sclerosing cholangitis is a unique condition that responds well to steroid therapy and should be distinguished from classical PSC and biliary malignancy.
Supporting Evidence
- IgG4 cholangiopathy can involve any level of the biliary tree.
- Most cases are associated with autoimmune pancreatitis.
- Steroid therapy is very effective even at disease relapse.
- Elevated serum IgG4 levels are the most specific indicator of the disease.
Takeaway
IgG4 cholangiopathy is a disease that affects the bile ducts and can be hard to diagnose, but it usually gets better with steroids.
Methodology
The diagnosis of IgG4 cholangiopathy is based on serological examinations, radiological features, and histological evidence of IgG4+ plasma cell infiltration.
Limitations
The diagnosis can be challenging, especially in cases without autoimmune pancreatitis, and many patients have been treated surgically for suspected malignancy.
Participant Demographics
Patients with IgG4 cholangiopathy often present with obstructive jaundice and may have other IgG4-related conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website